59 related articles for article (PubMed ID: 23232578)
1. Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.
Fransson S; Abel F; Kogner P; Martinsson T; Ejeskär K
Int J Oncol; 2013 Feb; 42(2):609-16. PubMed ID: 23232578
[TBL] [Abstract][Full Text] [Related]
2. High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival.
Fransson S; Ejeskär K
Med Oncol; 2013 Dec; 30(4):724. PubMed ID: 24026661
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
5. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.
Boller D; Schramm A; Doepfner KT; Shalaby T; von Bueren AO; Eggert A; Grotzer MA; Arcaro A
Clin Cancer Res; 2008 Feb; 14(4):1172-81. PubMed ID: 18281552
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
Fransson S; Martinsson T; Ejeskär K
Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
9. Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.
Fransson S; Kogner P; Martinsson T; Ejeskär K
J Mol Signal; 2013 Apr; 8(1):4. PubMed ID: 23597230
[TBL] [Abstract][Full Text] [Related]
10. Analysis of PI3K/AKT/mTOR signalling pathway in high risk neuroblastic tumours.
Iżycka-Świeszewska E; Drożyńska E; Rzepko R; Kobierska-Gulida G; Grajkowska W; Perek D; Balcerska A
Pol J Pathol; 2010; 61(4):192-8. PubMed ID: 21290341
[TBL] [Abstract][Full Text] [Related]
11. p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors.
Fransson S; Uv A; Eriksson H; Andersson MK; Wettergren Y; Bergo M; Ejeskär K
Oncogene; 2012 Jul; 31(27):3277-86. PubMed ID: 22020336
[TBL] [Abstract][Full Text] [Related]
12. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions.
Gómez-Villafuertes R; García-Huerta P; Díaz-Hernández JI; Miras-Portugal MT
Sci Rep; 2015 Dec; 5():18417. PubMed ID: 26687764
[TBL] [Abstract][Full Text] [Related]
14. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
15. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
[TBL] [Abstract][Full Text] [Related]
16. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
Zhang J; Zheng Y; Wang Y; Tong H
J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
18. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
19. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
[TBL] [Abstract][Full Text] [Related]
20. Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer.
Cui B; Tao J; Yang Y
Cell Biochem Biophys; 2012 Jan; 62(1):47-54. PubMed ID: 21910030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]